APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chemotherapy Induced Anemia Drug

Compare research editions
View pricing & licenses

Selected research

Industry Research

Chemotherapy Induced Anemia Drug Industry Research Report 2026

22 December 2025120 pages

Choose your research edition.

Industry ResearchChemotherapy Induced Anemia Drug Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Chemotherapy Induced Anemia Drug Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Chemotherapy Induced Anemia Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chemotherapy Induced Anemia Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Chemotherapy Induced Anemia Drug Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Chemotherapy Induced Anemia Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Chemotherapy Induced Anemia Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Chemotherapy Induced Anemia Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Chemotherapy Induced Anemia Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Chemotherapy Induced Anemia Drug include Chong Kun Dang Pharmaceutical Corp., Sandoz International GmbH, Pfizer Inc., Tolero Pharmaceuticals, Inc., Therapure Biopharma Inc., SBI Pharmaceuticals Co., Ltd., Pieris Pharmaceuticals Inc, PhytoHealth Corporation and PharmaEssentia Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Chemotherapy Induced Anemia Drug market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Chemotherapy Induced Anemia Drug Market by Company

Chong Kun Dang Pharmaceutical Corp.

Sandoz International GmbH

Pfizer Inc.

Tolero Pharmaceuticals, Inc.

Therapure Biopharma Inc.

SBI Pharmaceuticals Co., Ltd.

Pieris Pharmaceuticals Inc

PhytoHealth Corporation

PharmaEssentia Corporation

Panacea Biotec Limited

Galenica Ltd.

Dr. Reddy's Laboratories Limited

BIOCAD

3SBio Inc.

Chemotherapy Induced Anemia Drug Segment by Type

Pegylated Erythropoietin

Ferric Carboxymaltose

Epoetin Zeta Biosimilar

Others

Chemotherapy Induced Anemia Drug Segment by Application

Clinic

Hospital

Homecare

Chemotherapy Induced Anemia Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chemotherapy Induced Anemia Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chemotherapy Induced Anemia Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chemotherapy Induced Anemia Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Chemotherapy Induced Anemia Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Chemotherapy Induced Anemia Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Chemotherapy Induced Anemia Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Chemotherapy Induced Anemia Drug Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Chemotherapy Induced Anemia Drug Sales (k units) of Manufacturers (2021-2026) Table 7. Global Chemotherapy Induced Anemia Drug Sales Market Share by Manufacturers (2021-2026) Table 8. Global Chemotherapy Induced Anemia Drug Revenue of Manufacturers (2021-2026) Table 9. Global Chemotherapy Induced Anemia Drug Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Chemotherapy Induced Anemia Drug Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Chemotherapy Induced Anemia Drug Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Chemotherapy Induced Anemia Drug, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Chemotherapy Induced Anemia Drug, Product Type & Application Table 14. Global Chemotherapy Induced Anemia Drug Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Chemotherapy Induced Anemia Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Chong Kun Dang Pharmaceutical Corp. Company Information Table 19. Chong Kun Dang Pharmaceutical Corp. Business Overview Table 20. Chong Kun Dang Pharmaceutical Corp. Chemotherapy Induced Anemia Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Chong Kun Dang Pharmaceutical Corp. Chemotherapy Induced Anemia Drug Product Portfolio Table 22. Chong Kun Dang Pharmaceutical Corp. Recent Developments Table 23. Sandoz International GmbH Company Information Table 24. Sandoz International GmbH Business Overview Table 25. Sandoz International GmbH Chemotherapy Induced Anemia Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Sandoz International GmbH Chemotherapy Induced Anemia Drug Product Portfolio Table 27. Sandoz International GmbH Recent Developments Table 28. Pfizer Inc. Company Information Table 29. Pfizer Inc. Business Overview Table 30. Pfizer Inc. Chemotherapy Induced Anemia Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Pfizer Inc. Chemotherapy Induced Anemia Drug Product Portfolio Table 32. Pfizer Inc. Recent Developments Table 33. Tolero Pharmaceuticals, Inc. Company Information Table 34. Tolero Pharmaceuticals, Inc. Business Overview Table 35. Tolero Pharmaceuticals, Inc. Chemotherapy Induced Anemia Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Tolero Pharmaceuticals, Inc. Chemotherapy Induced Anemia Drug Product Portfolio Table 37. Tolero Pharmaceuticals, Inc. Recent Developments Table 38. Therapure Biopharma Inc. Company Information Table 39. Therapure Biopharma Inc. Business Overview Table 40. Therapure Biopharma Inc. Chemotherapy Induced Anemia Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Therapure Biopharma Inc. Chemotherapy Induced Anemia Drug Product Portfolio Table 42. Therapure Biopharma Inc. Recent Developments Table 43. SBI Pharmaceuticals Co., Ltd. Company Information Table 44. SBI Pharmaceuticals Co., Ltd. Business Overview Table 45. SBI Pharmaceuticals Co., Ltd. Chemotherapy Induced Anemia Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. SBI Pharmaceuticals Co., Ltd. Chemotherapy Induced Anemia Drug Product Portfolio Table 47. SBI Pharmaceuticals Co., Ltd. Recent Developments Table 48. Pieris Pharmaceuticals Inc Company Information Table 49. Pieris Pharmaceuticals Inc Business Overview Table 50. Pieris Pharmaceuticals Inc Chemotherapy Induced Anemia Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Pieris Pharmaceuticals Inc Chemotherapy Induced Anemia Drug Product Portfolio Table 52. Pieris Pharmaceuticals Inc Recent Developments Table 53. PhytoHealth Corporation Company Information Table 54. PhytoHealth Corporation Business Overview Table 55. PhytoHealth Corporation Chemotherapy Induced Anemia Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. PhytoHealth Corporation Chemotherapy Induced Anemia Drug Product Portfolio Table 57. PhytoHealth Corporation Recent Developments Table 58. PharmaEssentia Corporation Company Information Table 59. PharmaEssentia Corporation Business Overview Table 60. PharmaEssentia Corporation Chemotherapy Induced Anemia Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. PharmaEssentia Corporation Chemotherapy Induced Anemia Drug Product Portfolio Table 62. PharmaEssentia Corporation Recent Developments Table 63. Panacea Biotec Limited Company Information Table 64. Panacea Biotec Limited Business Overview Table 65. Panacea Biotec Limited Chemotherapy Induced Anemia Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Panacea Biotec Limited Chemotherapy Induced Anemia Drug Product Portfolio Table 67. Panacea Biotec Limited Recent Developments Table 68. Galenica Ltd. Company Information Table 69. Galenica Ltd. Business Overview Table 70. Galenica Ltd. Chemotherapy Induced Anemia Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Galenica Ltd. Chemotherapy Induced Anemia Drug Product Portfolio Table 72. Galenica Ltd. Recent Developments Table 73. Dr. Reddy's Laboratories Limited Company Information Table 74. Dr. Reddy's Laboratories Limited Business Overview Table 75. Dr. Reddy's Laboratories Limited Chemotherapy Induced Anemia Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Dr. Reddy's Laboratories Limited Chemotherapy Induced Anemia Drug Product Portfolio Table 77. Dr. Reddy's Laboratories Limited Recent Developments Table 78. BIOCAD Company Information Table 79. BIOCAD Business Overview Table 80. BIOCAD Chemotherapy Induced Anemia Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. BIOCAD Chemotherapy Induced Anemia Drug Product Portfolio Table 82. BIOCAD Recent Developments Table 83. 3SBio Inc. Company Information Table 84. 3SBio Inc. Business Overview Table 85. 3SBio Inc. Chemotherapy Induced Anemia Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. 3SBio Inc. Chemotherapy Induced Anemia Drug Product Portfolio Table 87. 3SBio Inc. Recent Developments Table 88. Global Chemotherapy Induced Anemia Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 89. Global Chemotherapy Induced Anemia Drug Sales by Region (2021-2026) & (k units) Table 90. Global Chemotherapy Induced Anemia Drug Sales Market Share by Region (2021-2026) Table 91. Global Chemotherapy Induced Anemia Drug Sales by Region (2027-2032) & (k units) Table 92. Global Chemotherapy Induced Anemia Drug Sales Market Share by Region (2027-2032) Table 93. Global Chemotherapy Induced Anemia Drug Revenue by Region (2021-2026) & (US$ Million) Table 94. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Region (2021-2026) Table 95. Global Chemotherapy Induced Anemia Drug Revenue by Region (2027-2032) & (US$ Million) Table 96. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Region (2027-2032) Table 97. North America Chemotherapy Induced Anemia Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. North America Chemotherapy Induced Anemia Drug Sales by Country (2021-2026) & (k units) Table 99. North America Chemotherapy Induced Anemia Drug Sales by Country (2027-2032) & (k units) Table 100. North America Chemotherapy Induced Anemia Drug Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Chemotherapy Induced Anemia Drug Revenue by Country (2027-2032) & (US$ Million) Table 102. Europe Chemotherapy Induced Anemia Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Europe Chemotherapy Induced Anemia Drug Sales by Country (2021-2026) & (k units) Table 104. Europe Chemotherapy Induced Anemia Drug Sales by Country (2027-2032) & (k units) Table 105. Europe Chemotherapy Induced Anemia Drug Revenue by Country (2021-2026) & (US$ Million) Table 106. Europe Chemotherapy Induced Anemia Drug Revenue by Country (2027-2032) & (US$ Million) Table 107. Asia Pacific Chemotherapy Induced Anemia Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Asia Pacific Chemotherapy Induced Anemia Drug Sales by Country (2021-2026) & (k units) Table 109. Asia Pacific Chemotherapy Induced Anemia Drug Sales by Country (2027-2032) & (k units) Table 110. Asia Pacific Chemotherapy Induced Anemia Drug Revenue by Country (2021-2026) & (US$ Million) Table 111. Asia Pacific Chemotherapy Induced Anemia Drug Revenue by Country (2027-2032) & (US$ Million) Table 112. South America Chemotherapy Induced Anemia Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. South America Chemotherapy Induced Anemia Drug Sales by Country (2021-2026) & (k units) Table 114. South America Chemotherapy Induced Anemia Drug Sales by Country (2027-2032) & (k units) Table 115. South America Chemotherapy Induced Anemia Drug Revenue by Country (2021-2026) & (US$ Million) Table 116. South America Chemotherapy Induced Anemia Drug Revenue by Country (2027-2032) & (US$ Million) Table 117. Middle East and Africa Chemotherapy Induced Anemia Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Middle East and Africa Chemotherapy Induced Anemia Drug Sales by Country (2021-2026) & (k units) Table 119. Middle East and Africa Chemotherapy Induced Anemia Drug Sales by Country (2027-2032) & (k units) Table 120. Middle East and Africa Chemotherapy Induced Anemia Drug Revenue by Country (2021-2026) & (US$ Million) Table 121. Middle East and Africa Chemotherapy Induced Anemia Drug Revenue by Country (2027-2032) & (US$ Million) Table 122. Global Chemotherapy Induced Anemia Drug Sales by Type (2021-2026) & (k units) Table 123. Global Chemotherapy Induced Anemia Drug Sales by Type (2027-2032) & (k units) Table 124. Global Chemotherapy Induced Anemia Drug Sales Market Share by Type (2021-2026) Table 125. Global Chemotherapy Induced Anemia Drug Sales Market Share by Type (2027-2032) Table 126. Global Chemotherapy Induced Anemia Drug Revenue by Type (2021-2026) & (US$ Million) Table 127. Global Chemotherapy Induced Anemia Drug Revenue by Type (2027-2032) & (US$ Million) Table 128. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Type (2021-2026) Table 129. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Type (2027-2032) Table 130. Global Chemotherapy Induced Anemia Drug Price by Type (2021-2026) & (US$/unit) Table 131. Global Chemotherapy Induced Anemia Drug Price by Type (2027-2032) & (US$/unit) Table 132. Global Chemotherapy Induced Anemia Drug Sales by Application (2021-2026) & (k units) Table 133. Global Chemotherapy Induced Anemia Drug Sales by Application (2027-2032) & (k units) Table 134. Global Chemotherapy Induced Anemia Drug Sales Market Share by Application (2021-2026) Table 135. Global Chemotherapy Induced Anemia Drug Sales Market Share by Application (2027-2032) Table 136. Global Chemotherapy Induced Anemia Drug Revenue by Application (2021-2026) & (US$ Million) Table 137. Global Chemotherapy Induced Anemia Drug Revenue by Application (2027-2032) & (US$ Million) Table 138. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Application (2021-2026) Table 139. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Application (2027-2032) Table 140. Global Chemotherapy Induced Anemia Drug Price by Application (2021-2026) & (US$/unit) Table 141. Global Chemotherapy Induced Anemia Drug Price by Application (2027-2032) & (US$/unit) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Chemotherapy Induced Anemia Drug Distributors List Table 145. Chemotherapy Induced Anemia Drug Customers List Table 146. Chemotherapy Induced Anemia Drug Industry Trends Table 147. Chemotherapy Induced Anemia Drug Industry Drivers Table 148. Chemotherapy Induced Anemia Drug Industry Restraints Table 149. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Chemotherapy Induced Anemia Drug Product Image Figure 5. Global Chemotherapy Induced Anemia Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Chemotherapy Induced Anemia Drug Market Size (2021-2032) & (US$ Million) Figure 7. Global Chemotherapy Induced Anemia Drug Sales (2021-2032) & (k units) Figure 8. Global Chemotherapy Induced Anemia Drug Average Price (US$/unit) & (2021-2032) Figure 9. Pegylated Erythropoietin Product Image Figure 10. Ferric Carboxymaltose Product Image Figure 11. Epoetin Zeta Biosimilar Product Image Figure 12. Others Product Image Figure 13. Clinic Product Image Figure 14. Hospital Product Image Figure 15. Homecare Product Image Figure 16. Global Chemotherapy Induced Anemia Drug Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Chemotherapy Induced Anemia Drug, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Chemotherapy Induced Anemia Drug Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Chemotherapy Induced Anemia Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Chemotherapy Induced Anemia Drug Sales by Region in 2025 Figure 22. Global Chemotherapy Induced Anemia Drug Revenue by Region in 2025 Figure 23. North America Chemotherapy Induced Anemia Drug Market Size by Country in 2025 Figure 24. North America Chemotherapy Induced Anemia Drug Sales Market Share by Country (2021-2032) Figure 25. North America Chemotherapy Induced Anemia Drug Revenue Market Share by Country (2021-2032) Figure 26. United States Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Chemotherapy Induced Anemia Drug Market Size by Country in 2025 Figure 30. Europe Chemotherapy Induced Anemia Drug Sales Market Share by Country (2021-2032) Figure 31. Europe Chemotherapy Induced Anemia Drug Revenue Market Share by Country (2021-2032) Figure 32. Germany Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Chemotherapy Induced Anemia Drug Market Size by Country in 2025 Figure 43. Asia Pacific Chemotherapy Induced Anemia Drug Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Chemotherapy Induced Anemia Drug Revenue Market Share by Country (2021-2032) Figure 45. China Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Chemotherapy Induced Anemia Drug Market Size by Country in 2025 Figure 54. South America Chemotherapy Induced Anemia Drug Sales Market Share by Country (2021-2032) Figure 55. South America Chemotherapy Induced Anemia Drug Revenue Market Share by Country (2021-2032) Figure 56. Brazil Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Chemotherapy Induced Anemia Drug Market Size by Country in 2025 Figure 60. Middle East and Africa Chemotherapy Induced Anemia Drug Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Chemotherapy Induced Anemia Drug Revenue Market Share by Country (2021-2032) Figure 62. Egypt Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Chemotherapy Induced Anemia Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Chemotherapy Induced Anemia Drug Sales Market Share by Type (2021-2032) Figure 68. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Type (2021-2032) Figure 69. Global Chemotherapy Induced Anemia Drug Price (US$/unit) by Type (2021-2032) Figure 70. Global Chemotherapy Induced Anemia Drug Sales Market Share by Application (2021-2032) Figure 71. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Application (2021-2032) Figure 72. Global Chemotherapy Induced Anemia Drug Price (US$/unit) by Application (2021-2032) Figure 73. Chemotherapy Induced Anemia Drug Value Chain Figure 74. Chemotherapy Induced Anemia Drug Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Chemotherapy Induced Anemia Drug Industry Opportunities and Challenges

Scope & coverage.

Types
  • Pegylated Erythropoietin
  • Ferric Carboxymaltose
  • Epoetin Zeta Biosimilar
  • Others
Applications
  • Clinic
  • Hospital
  • Homecare
Companies covered
  • Chong Kun Dang Pharmaceutical Corp.
  • Sandoz International GmbH
  • Pfizer Inc.
  • Tolero Pharmaceuticals, Inc.
  • Therapure Biopharma Inc.
  • SBI Pharmaceuticals Co., Ltd.
  • Pieris Pharmaceuticals Inc
  • PhytoHealth Corporation
  • PharmaEssentia Corporation
  • Panacea Biotec Limited
  • Galenica Ltd.
  • Dr. Reddy's Laboratories Limited
  • BIOCAD
  • 3SBio Inc.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Chemotherapy Induced Anemia Drug Market Size (2021-2032)
  4. 2.2.2 Global Chemotherapy Induced Anemia Drug Sales (2021-2032)
  5. 2.2.3 Global Chemotherapy Induced Anemia Drug Market Average Price (2021-2032)
  6. 2.3 Chemotherapy Induced Anemia Drug by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Pegylated Erythropoietin
  9. 2.3.3 Ferric Carboxymaltose
  10. 2.3.4 Epoetin Zeta Biosimilar
  11. 2.3.5 Others
  12. 2.4 Chemotherapy Induced Anemia Drug by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Clinic
  15. 2.4.3 Hospital
  16. 2.4.4 Homecare
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Chemotherapy Induced Anemia Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Chemotherapy Induced Anemia Drug Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Chemotherapy Induced Anemia Drug Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Chemotherapy Induced Anemia Drug Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Chemotherapy Induced Anemia Drug Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Chemotherapy Induced Anemia Drug, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Chemotherapy Induced Anemia Drug, Product Type & Application
  8. 3.8 Global Manufacturers of Chemotherapy Induced Anemia Drug, Established Date
  9. 3.9 Global Chemotherapy Induced Anemia Drug Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Chong Kun Dang Pharmaceutical Corp.
  2. 4.1.1 Chong Kun Dang Pharmaceutical Corp. Company Information
  3. 4.1.2 Chong Kun Dang Pharmaceutical Corp. Business Overview
  4. 4.1.3 Chong Kun Dang Pharmaceutical Corp. Chemotherapy Induced Anemia Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Chong Kun Dang Pharmaceutical Corp. Chemotherapy Induced Anemia Drug Product Portfolio
  6. 4.1.5 Chong Kun Dang Pharmaceutical Corp. Recent Developments
  7. 4.2 Sandoz International GmbH
  8. 4.2.1 Sandoz International GmbH Company Information
  9. 4.2.2 Sandoz International GmbH Business Overview
  10. 4.2.3 Sandoz International GmbH Chemotherapy Induced Anemia Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Sandoz International GmbH Chemotherapy Induced Anemia Drug Product Portfolio
  12. 4.2.5 Sandoz International GmbH Recent Developments
  13. 4.3 Pfizer Inc.
  14. 4.3.1 Pfizer Inc. Company Information
  15. 4.3.2 Pfizer Inc. Business Overview
  16. 4.3.3 Pfizer Inc. Chemotherapy Induced Anemia Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Pfizer Inc. Chemotherapy Induced Anemia Drug Product Portfolio
  18. 4.3.5 Pfizer Inc. Recent Developments
  19. 4.4 Tolero Pharmaceuticals, Inc.
  20. 4.4.1 Tolero Pharmaceuticals, Inc. Company Information
  21. 4.4.2 Tolero Pharmaceuticals, Inc. Business Overview
  22. 4.4.3 Tolero Pharmaceuticals, Inc. Chemotherapy Induced Anemia Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Tolero Pharmaceuticals, Inc. Chemotherapy Induced Anemia Drug Product Portfolio
  24. 4.4.5 Tolero Pharmaceuticals, Inc. Recent Developments
  25. 4.5 Therapure Biopharma Inc.
  26. 4.5.1 Therapure Biopharma Inc. Company Information
  27. 4.5.2 Therapure Biopharma Inc. Business Overview
  28. 4.5.3 Therapure Biopharma Inc. Chemotherapy Induced Anemia Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Therapure Biopharma Inc. Chemotherapy Induced Anemia Drug Product Portfolio
  30. 4.5.5 Therapure Biopharma Inc. Recent Developments
  31. 4.6 SBI Pharmaceuticals Co., Ltd.
  32. 4.6.1 SBI Pharmaceuticals Co., Ltd. Company Information
  33. 4.6.2 SBI Pharmaceuticals Co., Ltd. Business Overview
  34. 4.6.3 SBI Pharmaceuticals Co., Ltd. Chemotherapy Induced Anemia Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 SBI Pharmaceuticals Co., Ltd. Chemotherapy Induced Anemia Drug Product Portfolio
  36. 4.6.5 SBI Pharmaceuticals Co., Ltd. Recent Developments
  37. 4.7 Pieris Pharmaceuticals Inc
  38. 4.7.1 Pieris Pharmaceuticals Inc Company Information
  39. 4.7.2 Pieris Pharmaceuticals Inc Business Overview
  40. 4.7.3 Pieris Pharmaceuticals Inc Chemotherapy Induced Anemia Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Pieris Pharmaceuticals Inc Chemotherapy Induced Anemia Drug Product Portfolio
  42. 4.7.5 Pieris Pharmaceuticals Inc Recent Developments
  43. 4.8 PhytoHealth Corporation
  44. 4.8.1 PhytoHealth Corporation Company Information
  45. 4.8.2 PhytoHealth Corporation Business Overview
  46. 4.8.3 PhytoHealth Corporation Chemotherapy Induced Anemia Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 PhytoHealth Corporation Chemotherapy Induced Anemia Drug Product Portfolio
  48. 4.8.5 PhytoHealth Corporation Recent Developments
  49. 4.9 PharmaEssentia Corporation
  50. 4.9.1 PharmaEssentia Corporation Company Information
  51. 4.9.2 PharmaEssentia Corporation Business Overview
  52. 4.9.3 PharmaEssentia Corporation Chemotherapy Induced Anemia Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 PharmaEssentia Corporation Chemotherapy Induced Anemia Drug Product Portfolio
  54. 4.9.5 PharmaEssentia Corporation Recent Developments
  55. 4.10 Panacea Biotec Limited
  56. 4.10.1 Panacea Biotec Limited Company Information
  57. 4.10.2 Panacea Biotec Limited Business Overview
  58. 4.10.3 Panacea Biotec Limited Chemotherapy Induced Anemia Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Panacea Biotec Limited Chemotherapy Induced Anemia Drug Product Portfolio
  60. 4.10.5 Panacea Biotec Limited Recent Developments
  61. 4.11 Galenica Ltd.
  62. 4.11.1 Galenica Ltd. Company Information
  63. 4.11.2 Galenica Ltd. Business Overview
  64. 4.11.3 Galenica Ltd. Chemotherapy Induced Anemia Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Galenica Ltd. Chemotherapy Induced Anemia Drug Product Portfolio
  66. 4.11.5 Galenica Ltd. Recent Developments
  67. 4.12 Dr. Reddy's Laboratories Limited
  68. 4.12.1 Dr. Reddy's Laboratories Limited Company Information
  69. 4.12.2 Dr. Reddy's Laboratories Limited Business Overview
  70. 4.12.3 Dr. Reddy's Laboratories Limited Chemotherapy Induced Anemia Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Dr. Reddy's Laboratories Limited Chemotherapy Induced Anemia Drug Product Portfolio
  72. 4.12.5 Dr. Reddy's Laboratories Limited Recent Developments
  73. 4.13 BIOCAD
  74. 4.13.1 BIOCAD Company Information
  75. 4.13.2 BIOCAD Business Overview
  76. 4.13.3 BIOCAD Chemotherapy Induced Anemia Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 BIOCAD Chemotherapy Induced Anemia Drug Product Portfolio
  78. 4.13.5 BIOCAD Recent Developments
  79. 4.14 3SBio Inc.
  80. 4.14.1 3SBio Inc. Company Information
  81. 4.14.2 3SBio Inc. Business Overview
  82. 4.14.3 3SBio Inc. Chemotherapy Induced Anemia Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 3SBio Inc. Chemotherapy Induced Anemia Drug Product Portfolio
  84. 4.14.5 3SBio Inc. Recent Developments
5 Global Chemotherapy Induced Anemia Drug Market Scenario by Region
  1. 5.1 Global Chemotherapy Induced Anemia Drug Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Chemotherapy Induced Anemia Drug Sales by Region: 2021-2032
  3. 5.2.1 Global Chemotherapy Induced Anemia Drug Sales by Region: 2021-2026
  4. 5.2.2 Global Chemotherapy Induced Anemia Drug Sales by Region: 2027-2032
  5. 5.3 Global Chemotherapy Induced Anemia Drug Revenue by Region: 2021-2032
  6. 5.3.1 Global Chemotherapy Induced Anemia Drug Revenue by Region: 2021-2026
  7. 5.3.2 Global Chemotherapy Induced Anemia Drug Revenue by Region: 2027-2032
  8. 5.4 North America Chemotherapy Induced Anemia Drug Market Facts & Figures by Country
  9. 5.4.1 North America Chemotherapy Induced Anemia Drug Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Chemotherapy Induced Anemia Drug Sales by Country (2021-2032)
  11. 5.4.3 North America Chemotherapy Induced Anemia Drug Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Chemotherapy Induced Anemia Drug Market Facts & Figures by Country
  16. 5.5.1 Europe Chemotherapy Induced Anemia Drug Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Chemotherapy Induced Anemia Drug Sales by Country (2021-2032)
  18. 5.5.3 Europe Chemotherapy Induced Anemia Drug Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Chemotherapy Induced Anemia Drug Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Chemotherapy Induced Anemia Drug Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Chemotherapy Induced Anemia Drug Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Chemotherapy Induced Anemia Drug Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Chemotherapy Induced Anemia Drug Market Facts & Figures by Country
  41. 5.7.1 South America Chemotherapy Induced Anemia Drug Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Chemotherapy Induced Anemia Drug Sales by Country (2021-2032)
  43. 5.7.3 South America Chemotherapy Induced Anemia Drug Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Chemotherapy Induced Anemia Drug Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Chemotherapy Induced Anemia Drug Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Chemotherapy Induced Anemia Drug Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Chemotherapy Induced Anemia Drug Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Chemotherapy Induced Anemia Drug Sales by Type (2021-2032)
  2. 6.1.1 Global Chemotherapy Induced Anemia Drug Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Chemotherapy Induced Anemia Drug Sales Market Share by Type (2021-2032)
  4. 6.2 Global Chemotherapy Induced Anemia Drug Revenue by Type (2021-2032)
  5. 6.2.1 Global Chemotherapy Induced Anemia Drug Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Chemotherapy Induced Anemia Drug Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Chemotherapy Induced Anemia Drug Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Chemotherapy Induced Anemia Drug Sales by Application (2021-2032)
  2. 7.1.1 Global Chemotherapy Induced Anemia Drug Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Chemotherapy Induced Anemia Drug Sales Market Share by Application (2021-2032)
  4. 7.2 Global Chemotherapy Induced Anemia Drug Revenue by Application (2021-2032)
  5. 7.2.1 Global Chemotherapy Induced Anemia Drug Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Chemotherapy Induced Anemia Drug Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Chemotherapy Induced Anemia Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Chemotherapy Induced Anemia Drug Value Chain Analysis
  2. 8.1.1 Chemotherapy Induced Anemia Drug Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Chemotherapy Induced Anemia Drug Production Mode & Process
  5. 8.2 Chemotherapy Induced Anemia Drug Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Chemotherapy Induced Anemia Drug Distributors
  8. 8.2.3 Chemotherapy Induced Anemia Drug Customers
9 Global Chemotherapy Induced Anemia Drug Analyzing Market Dynamics
  1. 9.1 Chemotherapy Induced Anemia Drug Industry Trends
  2. 9.2 Chemotherapy Induced Anemia Drug Industry Drivers
  3. 9.3 Chemotherapy Induced Anemia Drug Industry Opportunities and Challenges
  4. 9.4 Chemotherapy Induced Anemia Drug Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst